secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001022079-25-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q4 revenue $2.62B (+14.5%), adjusted EPS $2.23 (+3.7%); raises dividend 6.7% to $0.80
--------------------------------------------------------------------------------

- Q4 revenue $2.62B (+14.5% YoY); reported diluted EPS $1.95 (+14.7%); adjusted diluted EPS $2.23 (+3.7%).
- Full year 2024 revenue $9.87B (+6.7%); reported EPS $7.69 (+2.7%); adjusted EPS $8.93 (+2.5%).
- FY2025 guidance: revenue $10.70-10.85B; reported EPS $8.34-8.59; adjusted EPS $9.55-9.80; cash ops ~$1.45B.
- Quarterly dividend raised 6.7% to $0.80 ($3.20 annual), payable Apr 21, 2025 to holders of record Apr 7, 2025.
- Completed 8 acquisitions in 2024 (including LifeLabs); extended health plan access to >90% of in-network lives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207925000008/0001022079-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207925000008/dgx-20250130.htm
  HTML page:      https://secwatch.observer/filing/0001022079-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer